Bronchodilators remain the cornerstone of the treatment of airway disorders such as asthma
and chronic obstructive pulmonary disease (COPD). There is therefore considerable interest …

Childhood asthma represents a heterogeneous challenging disease, in particular in its
severe forms. The identification of different asthma phenotypes has stimulated research in …

Allergic diseases and asthma are heterogenous chronic inflammatory conditions with
several distinct complex endotypes. Both environmental and genetic factors can influence …

Asthma is a common, chronic inflammatory airways disease characterized by a clinical
syndrome of bronchial hyperresponsiveness, inflammation, and reversible airflow …

Asthma exacerbations are associated with significant childhood morbidity and mortality.
Recurrent asthma attacks contribute to progressive loss of lung function and can sometimes …

Asthma is a frequent disease, mainly characterized by airway inflammation, in which drug
therapy is crucial in its management. The potential of pharmacogenomics testing in asthma …

The paradigm “one drug fits all” or “one dose fits all” will soon be challenged by
pharmacogenetics research and application. Drug response—efficacy or safety—depends …

Asthma is a common, complex, multifaceted disease. It comprises multiple phenotypes,
which might benefit from treatment with different types of innovative targeted therapies …

Background A new approach targeting aeroallergen sensing in the early events of mucosal
immunity could have greater benefit. The CSF1‐CSF1R pathway has a critical role in …

Asthma exacerbation prediction: recent insights : Current Opinion in Allergy and Clinical
Immunology Asthma exacerbation prediction: recent insights : Current Opinion in Allergy and …